Search
+
    SEARCHED FOR:

    STOCK MARKET SURGE

    US Stock Market: Investors turn to corporate earnings for clues on future market direction

    US equities enter a crucial week as heavy earnings flow tests the strength of the recent rally. Strong corporate results may sustain bullish sentiment, but elevated oil prices, geopolitical risks, and interest rate uncertainty continue to pose challenges, even as markets rebound sharply and approach record highs amid improving investor confidence globally.

    Polymarket in talks to raise money at about $15 billion valuation: The Information

    Prediction markets platform Polymarket is reportedly in talks to raise $400 million in funding at a $15 billion valuation. This potential investment follows a $600 million commitment from Intercontinental Exchange, the NYSE's parent company. Polymarket aims to attract further strategic investors, potentially bringing the total round to $1 billion as event-based trading gains significant traction.

    Smallcap stocks skyrocket up to 79% after crash. Is this breakout rally or bull trap?

    Indian smallcap stocks have surged dramatically in April, with some gaining up to 79%. The Nifty Smallcap 250 has outperformed the Nifty50, driven by domestic investor confidence. Experts are split on the sustainability of this rally, with some seeing a structural uptrend and others a sentiment-driven surge. Valuations are a concern for some, while others point to strong earnings.

    Trump accuses Iran of 'total violation' of ceasefire, threatens new attacks unless it takes deal

    In a heated exchange, US President Donald Trump labels Iran's actions as a breach of the ceasefire agreement, warning of severe repercussions including attacks on critical infrastructure like power plants and bridges if they don't comply. Meanwhile, his diplomatic team has embarked on a mission to Pakistan to navigate the escalating tensions.

    Charting the Global Economy: IMF trims world growth projections

    The International Monetary Fund has lowered its global growth forecast for 2026. This adjustment comes as the war in the Middle East has caused a significant oil price shock. The IMF also anticipates higher inflation due to rising energy and food costs.

    US Stocks | Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats up

    Kailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range. Strong investor demand reflects growing excitement around weight-loss and GLP-1 drugs, a market expected to expand rapidly as firms challenge pharma giants like Eli Lilly and Novo Nordisk.

    The Economic Times
    BACK TO TOP